Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Osteoporosis 1Multiple Myeloma 1

Interventions

Zoledronic Acid 16Risedronic Acid 9Vitamin D 8Calcium 8Letrozole 6Cholecalciferol 5Calcium Carbonate 5Alendronate 5Denosumab 4Absorptiometry, Photon 4Calcium Gluconate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Progesterone 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Goserelin 2Estradiol 2Calcium Citrate 2xian ling gu bao 1romosozumab 1X-Rays 1Toremifene 1Testosterone 1Technetium 1Spectrum Analysis 1Raloxifene Hydrochloride 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Osteoporosis × romosozumab × Clear all
NCT05775094 2025-12-19

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
10 enrolled
Plasma cell

Multiple Myeloma, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡